Clinical trialNCT02551159CompletedPhase 3Interventional

Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer

SponsorAstraZenecaEnrollment823Squamous Cell Carcinoma of the Head and Neck

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Richard Olsson
Study Director
clinicaltrials.gov ↗
Tanguy Seiwert
The University of Chicago, 5841 S Maryland Ave, Chicago, IL 60637
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

197 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria

Research Site
Graz, Austria
Research Site
Innsbruck, Austria
Research Site
Linz, Austria
Research Site
Vienna, Austria

Belgium

Research Site
Brussels, Belgium
Research Site
Brussels, Belgium
Research Site
Brussels, Belgium
Research Site
Leuven, Belgium
Research Site
Namur, Belgium

Brazil

Research Site
Barretos, Brazil
Research Site
Curitiba, Brazil
Research Site
Florianópolis, Brazil
Research Site
Ijuí, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Recife, Brazil
Research Site
Rio de Janeiro, Brazil
Research Site
Santo André, Brazil
Research Site
Santo André, Brazil
Research Site
São José do Rio Preto, Brazil
Research Site
São Paulo, Brazil

Canada

Research Site
Calgary, Alberta, Canada
Research Site
Winnipeg, Manitoba, Canada
Research Site
Moncton, New Brunswick, Canada
Research Site
Halifax, Nova Scotia, Canada
Research Site
Hamilton, Ontario, Canada
Research Site
London, Ontario, Canada
Research Site
Ottawa, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Montreal, Quebec, Canada

France

Research Site
Bordeaux, France
Research Site
Brest, France
Research Site
Dijon, France
Research Site
Lyon, France
Research Site
Nice, France
Research Site
Paris, France
Research Site
Poitiers, France
Research Site
Toulouse, France
Research Site
Vandœuvre-lès-Nancy, France

157 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 15 Oct 2015
Primary completion: 6 Jul 2020
Completion: 21 May 2021
Last update posted: 13 Oct 2021
Registered enrollment: 823
Registry id: NCT02551159

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.